BNP Paribas Financial Markets’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $345K | Sell |
|
|||||
|
2025
Q2 | $1.94M | Buy |
|
|||||
|
2025
Q1 | $399K | Sell |
|
|||||
|
2024
Q4 | $644K | Buy |
|
|||||
|
2024
Q3 | $311K | Sell |
|
|||||
|
2024
Q2 | $378K | Sell |
|
|||||
|
2024
Q1 | $1.69M | Buy |
|
|||||
|
2023
Q4 | $175K | Sell |
|
|||||
|
2023
Q3 | $222K | Buy |
|
|||||
|
2023
Q2 | $104K | Sell |
|
|||||
|
2023
Q1 | $254K | Buy |
|
|||||
|
2022
Q4 | $45.3K | Sell |
|
|||||
|
2022
Q3 | $319K | Sell |
|
|||||
|
2022
Q2 | $427K | Sell |
|
|||||
|
2022
Q1 | $703K | Sell |
|
|||||
|
2021
Q4 | $1.25M | Buy |
|
|||||
|
2021
Q3 | $136K | Buy |
|
|||||
|
2021
Q2 | $40.4K | Sell |
|
|||||
|
2021
Q1 | $157K | Sell |
|
|||||
|
2020
Q4 | $277K | Sell |
|
|||||
|
2020
Q3 | $109K | Buy |
|
|||||
|
2020
Q2 | $17.7K | Sell |
|
|||||
|
2020
Q1 | $65.1K | Buy |
|
|||||
|
2019
Q4 | $25.1K | Buy |
|
|||||
|
2019
Q3 | $18K | Buy |
|
|||||
|
2019
Q2 | $17.9K | Sell |
|
|||||
|
2019
Q1 | $29.8K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $7.39K | Hold |
|
|||||
|
2018
Q2 | $7.25K | Sell |
|
|||||
|
2018
Q1 | $41.7K | Buy |
|
|||||
|
2017
Q4 | $23.6K | Buy |
|
|||||
|
2017
Q3 | $15.1K | Sell |
|
|||||
|
2017
Q2 | $27.3K | Buy |
|
|||||
|
2017
Q1 | $752 | Sell |
|
|||||
|
2016
Q4 | $8.73K | Sell |
|
|||||
|
2016
Q3 | $8.32K | Buy |
|
|||||
|
2016
Q2 | $3.48K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $25.9K | Sell |
|
|||||
|
2015
Q3 | $44.6K | Buy |
|
|||||
|
2015
Q2 | $22.8K | Buy |
|
|||||
|
2015
Q1 | $5.5K | Buy |
|